Scinai Immunotherapeutics (SCNI) Equity Ratio (2024 - 2025)
Scinai Immunotherapeutics (SCNI) has disclosed Equity Ratio for 2 consecutive years, with 0.7 as the latest value for Q4 2025.
- Quarterly Equity Ratio fell 6.06% to 0.7 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.7 through Dec 2025, down 6.06% year-over-year, with the annual reading at 0.7 for FY2025, 6.06% down from the prior year.
- Equity Ratio hit 0.7 in Q4 2025 for Scinai Immunotherapeutics, down from 0.74 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.74 in Q4 2024 to a low of 0.7 in Q4 2025.